| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. | Cancer Discov | 2015 | 1.67 |
| 2 | Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade. | Cancer Immunol Res | 2016 | 0.88 |
| 3 | Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing. | Clin Cancer Res | 2016 | 0.82 |
| 4 | Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. | Clin Cancer Res | 2016 | 0.80 |
| 5 | Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer. | Clin Cancer Res | 2016 | 0.76 |